SeaStar Medical (NASDAQ:ICU) Cut to “Sell” at Wall Street Zen

Wall Street Zen cut shares of SeaStar Medical (NASDAQ:ICU) from a hold rating to a sell rating in a report released on Sunday.

Other analysts also recently issued reports about the stock. Maxim Group set a $8.00 price objective on shares of SeaStar Medical and gave the company a “buy” rating in a research report on Thursday, May 14th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of SeaStar Medical in a report on Friday, July 17th. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $8.00.

SeaStar Medical Trading Down 0.3%

SeaStar Medical stock opened at $3.18 on Friday. SeaStar Medical has a 12 month low of $2.07 and a 12 month high of $12.50. The company has a market capitalization of $14.02 million, a price-to-earnings ratio of -0.81 and a beta of -1.05. The business’s fifty day simple moving average is $3.71 and its two-hundred day simple moving average is $3.46.

SeaStar Medical (NASDAQ:ICU) last issued its quarterly earnings results on Wednesday, August 12th. The company reported ($0.91) earnings per share for the quarter, beating the consensus estimate of ($0.97) by $0.06. The firm had revenue of $0.61 million during the quarter, compared to the consensus estimate of $0.49 million. SeaStar Medical had a negative return on equity of 162.75% and a negative net margin of 795.51%. On average, equities research analysts predict that SeaStar Medical will post -3.66 EPS for the current year.

Institutional Investors Weigh In On SeaStar Medical

Several institutional investors have recently modified their holdings of the business. XTX Topco Ltd increased its holdings in SeaStar Medical by 395.4% in the 2nd quarter. XTX Topco Ltd now owns 60,983 shares of the company’s stock worth $26,000 after buying an additional 48,674 shares in the last quarter. Jane Street Group LLC bought a new position in SeaStar Medical during the 4th quarter valued at about $30,000. Finally, Millennium Management LLC bought a new position in SeaStar Medical during the 3rd quarter valued at about $102,000. 1.69% of the stock is owned by hedge funds and other institutional investors.

About SeaStar Medical

SeaStar Medical, Inc (NASDAQ: ICU) is a medical device company focused on the development and commercialization of cerebral embolic protection systems for patients undergoing transcatheter aortic valve replacement (TAVR) procedures. The company’s mission is to reduce the risk of stroke and other neurologic events associated with structural heart interventions by capturing or deflecting embolic debris that can travel to the brain during catheter-based therapies.

The company’s flagship product, TriGUARD® 3, is a next-generation embolic deflection device designed to provide coverage of all three cerebral vessels during TAVR.